AMERICAN HEALTHCARE REIT INC (AHR) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:AHR - US3981823038 - REIT
48.64 USD
+1.24 (+2.62%)
48.67 USD
+0.03 (+0.06%)
Overall AHR gets a fundamental rating of 3 out of 10. We evaluated AHR against 125 industry peers in the Diversified REITs industry. Both the profitability and financial health of AHR have multiple concerns. AHR is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
- AHR had positive earnings in the past year.
- In the past year AHR had a positive cash flow from operations.
1.2 Ratios
- AHR has a Return On Assets of 0.57%. This is comparable to the rest of the industry: AHR outperforms 46.40% of its industry peers.
- AHR has a Return On Equity of 1.02%. This is comparable to the rest of the industry: AHR outperforms 45.60% of its industry peers.
- With a Return On Invested Capital value of 3.09%, AHR perfoms like the industry average, outperforming 60.00% of the companies in the same industry.
- AHR had an Average Return On Invested Capital over the past 3 years of 1.94%. This is in line with the industry average of 3.07%.
- The 3 year average ROIC (1.94%) for AHR is below the current ROIC(3.09%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.57% | ||
| ROE | 1.02% | ||
| ROIC | 3.09% |
ROA(3y)-1.37%
ROA(5y)N/A
ROE(3y)-4.37%
ROE(5y)N/A
ROIC(3y)1.94%
ROIC(5y)N/A
1.3 Margins
- With a Profit Margin value of 1.24%, AHR perfoms like the industry average, outperforming 44.00% of the companies in the same industry.
- The Operating Margin of AHR (7.70%) is worse than 79.20% of its industry peers.
- In the last couple of years the Operating Margin of AHR has grown nicely.
- AHR has a worse Gross Margin (20.69%) than 91.20% of its industry peers.
- AHR's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.7% | ||
| PM (TTM) | 1.24% | ||
| GM | 20.69% |
OM growth 3Y31.86%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.79%
GM growth 5YN/A
2. Health
2.1 Basic Checks
- AHR has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
- The number of shares outstanding for AHR has been increased compared to 1 year ago.
- AHR has a better debt/assets ratio than last year.
2.2 Solvency
- An Altman-Z score of 2.72 indicates that AHR is not a great score, but indicates only limited risk for bankruptcy at the moment.
- AHR's Altman-Z score of 2.72 is amongst the best of the industry. AHR outperforms 96.00% of its industry peers.
- A Debt/Equity ratio of 0.58 indicates that AHR is somewhat dependend on debt financing.
- AHR's Debt to Equity ratio of 0.58 is amongst the best of the industry. AHR outperforms 86.40% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.58 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 2.72 |
ROIC/WACC0.38
WACC8.06%
2.3 Liquidity
- A Current Ratio of 0.76 indicates that AHR may have some problems paying its short term obligations.
- With a Current ratio value of 0.76, AHR is not doing good in the industry: 60.80% of the companies in the same industry are doing better.
- AHR has a Quick Ratio of 0.76. This is a bad value and indicates that AHR is not financially healthy enough and could expect problems in meeting its short term obligations.
- AHR has a Quick ratio (0.76) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.76 | ||
| Quick Ratio | 0.76 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 155.32% over the past year.
- Looking at the last year, AHR shows a quite strong growth in Revenue. The Revenue has grown by 9.36% in the last year.
- AHR shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 17.32% yearly.
EPS 1Y (TTM)155.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%900%
Revenue 1Y (TTM)9.36%
Revenue growth 3Y17.32%
Revenue growth 5YN/A
Sales Q2Q%9.38%
3.2 Future
- The Earnings Per Share is expected to grow by 75.49% on average over the next years. This is a very strong growth
- Based on estimates for the next years, AHR will show a quite strong growth in Revenue. The Revenue will grow by 15.03% on average per year.
EPS Next Y256.18%
EPS Next 2Y117.16%
EPS Next 3Y75.49%
EPS Next 5YN/A
Revenue Next Year10.86%
Revenue Next 2Y11.16%
Revenue Next 3Y11.02%
Revenue Next 5Y15.03%
3.3 Evolution
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
- AHR is valuated quite expensively with a Price/Earnings ratio of 187.08.
- Compared to the rest of the industry, the Price/Earnings ratio of AHR indicates a slightly more expensive valuation: AHR is more expensive than 64.00% of the companies listed in the same industry.
- The average S&P500 Price/Earnings ratio is at 27.32. AHR is valued rather expensively when compared to this.
- A Price/Forward Earnings ratio of 66.33 indicates a quite expensive valuation of AHR.
- AHR's Price/Forward Earnings is on the same level as the industry average.
- AHR's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 24.30.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 187.08 | ||
| Fwd PE | 66.33 |
4.2 Price Multiples
- AHR's Enterprise Value to EBITDA ratio is rather expensive when compared to the industry. AHR is more expensive than 93.60% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 30.21 |
4.3 Compensation for Growth
- The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- AHR's earnings are expected to grow with 75.49% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.73
PEG (5Y)N/A
EPS Next 2Y117.16%
EPS Next 3Y75.49%
5. Dividend
5.1 Amount
- AHR has a Yearly Dividend Yield of 2.08%. Purely for dividend investing, there may be better candidates out there.
- Compared to an average industry Dividend Yield of 6.59, AHR's dividend is way lower than its industry peers. On top of this 86.40% of the companies listed in the same industry pay a better dividend than AHR!
- AHR's Dividend Yield is comparable with the S&P500 average which is at 1.86.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.08% |
5.2 History
- AHR does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
- AHR pays out 583.20% of its income as dividend. This is not a sustainable payout ratio.
DP583.2%
EPS Next 2Y117.16%
EPS Next 3Y75.49%
48.64
+1.24 (+2.62%)
Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)11-06 2025-11-06/amc
Earnings (Next)02-26 2026-02-26/amc
Inst Owners84.5%
Inst Owner Change0.2%
Ins Owners0.73%
Ins Owner Change-2.51%
Market Cap9.12B
Revenue(TTM)2.20B
Net Income(TTM)27.26M
Analysts83.75
Price Target57.21 (17.62%)
Short Float %9.99%
Short Ratio9.08
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.08% |
Yearly Dividend1.08
Dividend Growth(5Y)N/A
DP583.2%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)43.29%
Min EPS beat(2)33.28%
Max EPS beat(2)53.31%
EPS beat(4)3
Avg EPS beat(4)-50.49%
Min EPS beat(4)-359.9%
Max EPS beat(4)71.36%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.6%
Min Revenue beat(2)-1.37%
Max Revenue beat(2)2.57%
Revenue beat(4)1
Avg Revenue beat(4)0.2%
Min Revenue beat(4)-1.37%
Max Revenue beat(4)2.57%
Revenue beat(8)4
Avg Revenue beat(8)0.94%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)20.83%
EPS NQ rev (1m)2.6%
EPS NQ rev (3m)-8.41%
EPS NY rev (1m)0%
EPS NY rev (3m)19.29%
Revenue NQ rev (1m)2.65%
Revenue NQ rev (3m)7.63%
Revenue NY rev (1m)0.84%
Revenue NY rev (3m)2.02%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 187.08 | ||
| Fwd PE | 66.33 | ||
| P/S | 4.15 | ||
| P/FCF | N/A | ||
| P/OCF | 30.52 | ||
| P/B | 3.4 | ||
| P/tB | 4.03 | ||
| EV/EBITDA | 30.21 |
EPS(TTM)0.26
EY0.53%
EPS(NY)0.73
Fwd EY1.51%
FCF(TTM)-0.85
FCFYN/A
OCF(TTM)1.59
OCFY3.28%
SpS11.73
BVpS14.29
TBVpS12.06
PEG (NY)0.73
PEG (5Y)N/A
Graham Number9.14
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.57% | ||
| ROE | 1.02% | ||
| ROCE | 3.91% | ||
| ROIC | 3.09% | ||
| ROICexc | 3.2% | ||
| ROICexgc | 3.59% | ||
| OM | 7.7% | ||
| PM (TTM) | 1.24% | ||
| GM | 20.69% | ||
| FCFM | N/A |
ROA(3y)-1.37%
ROA(5y)N/A
ROE(3y)-4.37%
ROE(5y)N/A
ROIC(3y)1.94%
ROIC(5y)N/A
ROICexc(3y)1.97%
ROICexc(5y)N/A
ROICexgc(3y)2.22%
ROICexgc(5y)N/A
ROCE(3y)2.45%
ROCE(5y)N/A
ROICexgc growth 3Y56.38%
ROICexgc growth 5YN/A
ROICexc growth 3Y56.96%
ROICexc growth 5YN/A
OM growth 3Y31.86%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.79%
GM growth 5YN/A
F-Score8
Asset Turnover0.46
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.58 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 4.46 | ||
| Cap/Depr | 256.07% | ||
| Cap/Sales | 20.86% | ||
| Interest Coverage | 1.95 | ||
| Cash Conversion | 85.75% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.76 | ||
| Quick Ratio | 0.76 | ||
| Altman-Z | 2.72 |
F-Score8
WACC8.06%
ROIC/WACC0.38
Cap/Depr(3y)83.56%
Cap/Depr(5y)N/A
Cap/Sales(3y)7.98%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)155.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%900%
EPS Next Y256.18%
EPS Next 2Y117.16%
EPS Next 3Y75.49%
EPS Next 5YN/A
Revenue 1Y (TTM)9.36%
Revenue growth 3Y17.32%
Revenue growth 5YN/A
Sales Q2Q%9.38%
Revenue Next Year10.86%
Revenue Next 2Y11.16%
Revenue Next 3Y11.02%
Revenue Next 5Y15.03%
EBIT growth 1Y34.52%
EBIT growth 3Y54.7%
EBIT growth 5YN/A
EBIT Next Year163.2%
EBIT Next 3Y51.64%
EBIT Next 5Y38.05%
FCF growth 1Y151.02%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y78.71%
OCF growth 3Y114.22%
OCF growth 5YN/A
AMERICAN HEALTHCARE REIT INC / AHR FAQ
What is the ChartMill fundamental rating of AMERICAN HEALTHCARE REIT INC (AHR) stock?
ChartMill assigns a fundamental rating of 3 / 10 to AHR.
Can you provide the valuation status for AMERICAN HEALTHCARE REIT INC?
ChartMill assigns a valuation rating of 2 / 10 to AMERICAN HEALTHCARE REIT INC (AHR). This can be considered as Overvalued.
What is the profitability of AHR stock?
AMERICAN HEALTHCARE REIT INC (AHR) has a profitability rating of 3 / 10.
What is the expected EPS growth for AMERICAN HEALTHCARE REIT INC (AHR) stock?
The Earnings per Share (EPS) of AMERICAN HEALTHCARE REIT INC (AHR) is expected to grow by 256.18% in the next year.
How sustainable is the dividend of AMERICAN HEALTHCARE REIT INC (AHR) stock?
The dividend rating of AMERICAN HEALTHCARE REIT INC (AHR) is 1 / 10 and the dividend payout ratio is 583.2%.